Managing the challenge of a global healthcare crisis such as the COVID-19 pandemic requires collaboration, clear and abundant communication, and planning to allow a healthcare system to adapt.
ARUP Consult® added new resources in September that provide expert guidance on preoperative testing for ovarian cancer biomarkers and testing strategies for malaria.
Although vaccines have not brought the pandemic to its end, they have proven to be a potent tool in blocking the spread of the virus. But many wonder whether antibodies are doing their job.
ARUP Laboratories has reconstructed an additional lab dedicated solely to high-throughput COVID-19 molecular diagnostic testing to meet renewed demand for testing.
A new antibody test that has earned EUA from the FDA effectively detects SARS-CoV-2 neutralizing antibodies, according to an analysis recently published by experts at ARUP Laboratories.
Rapid antigen testing has been used widely during the COVID-19 pandemic to determine infection status in settings such as schools or workplaces, but its role has changed as the pandemic has evolved.
The University of Utah, ARUP Laboratories, and Techcyte Inc. announced that they have formed a partnership to develop NanoSpot.AI, a less than five-minute, easy-to-administer SARS-CoV-2 antibody test.
ARUP’s Adam Barker, PhD, will be the featured presenter during the Dark Intelligence Group’s COVID-19 STAT Intelligence Briefing at 10 a.m. MDT on Tuesday, April 27.
Patricia Slev, PhD, ARUP Immunology Division section chief and University of Utah associate professor of pathology, is an author of newly published COVID-19 antibody testing guidelines.
The CDC has cited research in which the University of Utah’s HERO Project and ARUP Laboratories played a key role. The research is integral to new physical distancing guidelines.